On the pangolin story that is still drawing breath, "(Shi Zhengli, WIV) said that if the intermediate host was the pangolin.. it’s possible the virus jumped from bats to pangolins outside China.. smuggled in from other Asian nations, including India." theguardian.com/world/2020/dec…
Thankfully, before scientists go on a wild goose chase to sample pangolins in India, David Robertson (U of Glasgow), who was also interviewed, said, “We’re fairly confident the pangolins have picked up their virus, presumably from horseshoe bats, after being imported into China.”
If any pangolins need to be investigated, I recommend starting with the Guangdong pangolins confiscated in March, 2019. This is the only batch of pangolins with a CoV that has a SARS2-like Spike RBD. Many questions remain re: the sample histories and data. biorxiv.org/content/10.110…
Closest virus relatives to SARS2 found in Yunnan province, China. No pangolin CoVs found in Malaysia for the past decade. Only 2 pangolin CoVs found in Guangdong and Guangxi province, China.
Their conclusion: let's look in South Asia, including India.
Have to knock on journalists a bit. Not the first time today, while reading news articles @nytimes@guardian noticed no links to the studies cited.
"Analysis the team published in October indicated that some were already capable of invading human cells..." theguardian.com/world/2020/dec…
Not sure why SARS-like CoVs from nature being capable of infecting human cells is so surprising - WIV already published this in 2013: "bat SL-CoV-WIV1 can grow in human alveolar basal epithelial..." nature.com/articles/natur…
"ability of SL-CoV-WIV1 to use human ACE2.. suggests that direct bat-to-human infection is a plausible scenario"
And in 2015: "circulating bat CoV pools maintain 'poised' spike proteins that are capable of infecting humans without mutation or adaptation" nature.com/articles/nm.39…
Sep '19 paper: "proven potential of some SARSr-CoVs currently circulating in bats in southern China, to infect human cells, cause clinical signs in humanized mouse models.. infections that cannot be treated with monoclonal therapies effective against SARS" sciencedirect.com/science/articl…
In @guardian article, Shi also speculates that SARS2 could've been in intermediate hosts or humans “for a very long time”... in this scenario, where could a highly infectious SARS virus be circulating undetected prior to outbreak in Wuhan?
"1,596 residents were enrolled in the study from 2015 to 2017" in "Yunnan, Guangxi, and Guangdong, China, which are known for their high levels of wildlife biodiversity, active wildlife trade activity, and historic zoonotic disease emergence events" sciencedirect.com/science/articl…
"participants were asked to provide a blood sample... and an oropharyngeal swab (stored in a cryotube with viral transport medium)."
The paper reported 0.6% seropositivity for SARS-CoVs, but doesn't report if any of the ~1,500 swabs had SARS-CoVs. sciencedirect.com/science/articl…
In essence, a multiyear (2015-2017) survey in rural communities most at risk of SARS virus exposure found very low seropositivity (0.6% rural; 2.7% people living near bat caves), and did not report detecting -any- SARS-related CoV in ~1,500 human samples. ncbi.nlm.nih.gov/pmc/articles/P…
In comparison, the first covid case in Singapore was confirmed on Jan 23; by Mar 16, 7 clusters (243 cases) of local transmission had been identified, even in a country where strong public health measures had been rapidly implemented from Jan 3 onwards. channelnewsasia.com/news/singapore…
Considering how fast this virus spreads, even with public health measures in place, not to mention if undetected + no measures taken, makes me question how likely it is that covid was already in other populous cities prior to the outbreak in Wuhan.
Similar situation in South Korea: first covid case confirmed Jan 20, "became the second most infected country after China by early March" despite again massive, rapid efforts by the South Korean government and people to contain the outbreak. csis.org/analysis/timel…
Thailand & Japan are in the top three Wuhan air travel destinations:
Even if one speculates that a remotely located village was where the virus was pre-circulating+adapting/diversifying in animals/humans, how did sars2 break out only in Wuhan at first? Much more difficult to believe that sars2 originated as far away as India, Barcelona, or Italy.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
I'm hoping that one effect of the pandemic is that journals will start publishing peer reviews so that readers can quickly grasp the strengths and weaknesses of each paper.
Without published peer reviews, we need to rely on experts critiquing papers on twitter every weekend.
Peer reviews are performed by other experts in the same or similar fields, who spend hours to days reading and critiquing a paper.
This is real work. By highly skilled experts. That is also unpaid, no tangible incentives. Yet, not published unless a journal has open peer review.
It costs next to nothing to publish peer reviews online or as a supplementary file. But the value! Even people outside the field can see what questions the experts asked, were these addressed in the revisions? Were reviews fair, totally overboard, or negligent (just publish it)?
"You may disagree with their unconventional approach, but the truth is that these people behave, to all intents and purposes, like a small scientific community: they search and analyze data, they share and discuss their findings and, more importantly, they make discoveries."
Timely piece by @emmecola on how a coalition of twitter users, several anonymous, have been at the front of investigating the origins and sample history of RaTG13 + connection to SARS-like cases among miners from a Yunnan mine full of bats in 2012. mygenomix.medium.com/the-origin-of-…
Their work and fringe (I say this positively) influence on scientists & journalists has led to measurable outcomes. Namely, this @Nature addendum, confirming that RaTG13=4991; was seq'ed in 2018, not post-covid; linked to severe respiratory cases in 2012. nature.com/articles/s4158…
Latinne et al. (EcoHealth, WIV et al.) say "Our host datasets included.. 528 β-CoV sequences (273 new sequences, including 97 new SARSr-CoV sequences (Sarbecovirus) from 31 bat species"
@shingheizhan and I just submitted for peer review our rewritten pangolin CoV manuscript within a mini-review of what we currently know about RaTG13 and the chances of natural spillover in Wuhan. We are hopeful that it gets through this time and will be published in early 2021.
The story about the possible intermediate host and how SARS-CoV-2 spilled over into humans has changed so much over the past year. We were told in Jan that the virus came from wild animals sold at the market. And then in Feb that it was likely pangolins...
All of these trails have fizzled out... leaving no trace of an intermediate host, no clear evidence of natural spillover, while the closest virus relatives are from bats in Yunnan, a thousand miles away from Wuhan city.
It's not impossible that SARS-CoV-2 arrived in Europe and the US in Dec 2019, but consider that out of 640 throat swabs from Wuhan patients w influenza-like illness, Oct 2019-Jan 2020, only (9) samples in January tested positive for SARS-CoV-2. nature.com/articles/s4156…
Even in the city where cases were detected in Nov 2019, even when only patients with influenza-like illness are considered (not random blood donors), the virus could only be detected in January 2020 patient samples.
A month before, one of the first whistleblowers was made to sign a letter on Jan 3, 2020 confessing to spreading rumors and violating the law.
"In the future, doctors will be more afraid to issue early warnings when they find signs of infectious diseases." bbc.com/news/world-asi…
The day after Dr. Li signed the letter, a leading Chinese vaccine developer Sinopharm kicked into high gear manufacturing a covid vaccine on Jan 4; 2 weeks before China confirmed human-to-human transmission.
Thanks @norman7177@dktatlow for sources.